Brock Pledger

Development Manager at Amgen, Inc.

Brock Pledger

Brock Pledger

Development Manager at Amgen, Inc.

Overview
RelSci Relationships

1756

Contact Data
Trying to get in touch with Brock Pledger? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Brock Pledger likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at Change Healthcare Operations LLC

Relationship likelihood: Weak

Executive Vice President, Human Resources at Amgen, Inc.

Relationship likelihood: Weak

Chief Medical Officer at Matinas BioPharma Holdings, Inc.

Relationship likelihood: Weak

Executive Vice President, Global Commercial Operations at Amgen, Inc.

Relationship likelihood: Weak

Former Chief Commercial Officer at Gilead Sciences, Inc.

Relationship likelihood: Weak

Executive Vice President, Operations at Amgen, Inc.

Relationship likelihood: Weak

Executive Vice President, Research & Development at Amgen, Inc.

Relationship likelihood: Weak

Former Executive Director, Technical Accounting & External Reporting at Amgen, Inc.

Relationship likelihood: Weak

Principal at Amgen, Inc.

Relationship likelihood: Weak

Principal at Amgen, Inc.

Relationship likelihood: Weak

Paths to Brock Pledger
Potential Connections via
Relationship Science
You
Brock Pledger
Development Manager at Amgen, Inc.
Career History
Development Manager
Tenure Unconfirmed

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Other Affiliations

Brock Pledger is affiliated with Amgen, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brock Pledger. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brock Pledger's profile does not indicate a business or promotional relationship of any kind between RelSci and Brock Pledger.